Development of fluorescent probes that bind and stain amyloid plaques in Alzheimer’s disease
- 696 Downloads
β-amyloid (Aβ) plaques in the brain are composed of Aβ40 and Aβ42 peptides, and are the defining pathological feature of Alzheimer’s disease (AD). Fluorescent probes that can detect Aβ plaques have gained increasing interest as potential tools for in vitro and in vivo monitoring of the progression of AD. In this study, chalcone-mimic fluorescent probe 5 was designed and prepared. Probe 5 exhibited an approximately 50-fold increase in emission intensity after mixing with Aβ42 aggregates, a high affinity for Aβ42 aggregates (K D = 1.59 μM), and reasonable lipophilicity (log P value = 2.55). Probe 5 also exhibited specific staining of Aβ plaques in the transgenic mice (APP/PS1) brain sections. Ex vivo fluorescence imaging of the brain from normal and TG mice revealed that probe 5 was able to penetrate the BBB and stain the Aβ plaques. These results suggest that chalcone-mimic probe 5 possessed the requirements of a fluorescent probe for Aβ plaques and may be useful in AD research.
KeywordsAlzheimer’s disease (AD) Aβ plaques Fluorescent probe Chalcone-mimic probes
This work was supported by the Nuclear R&D Program from the Ministry of Education, Science and Technology (MEST).
- Hintersteiner, M., A. Enz, P. Frey, A.L. Jaton, W. Kinzy, R. Kneuer, U. Neumann, M. Rudin, M. Staufenbiel, M. Stoeckli, K.H. Wiederhold, and H.U. Gremlich. 2005. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe. Nature Biotechnology 23: 577–583.CrossRefPubMedGoogle Scholar
- Hong, M.C., Y.K. Kim, J.Y. Choi, S.Q. Yang, H. Rhee, Y.H. Ryu, T.H. Choi, G.J. Cheon, G.I. An, H.Y. Kim, Y. Kim, D.J. Kim, J.S. Lee, Y.T. Chang, and K.C. Lee. 2010. Synthesis and evaluation of stilbene derivatives as a potential imaging agent of amyloid plaques. Bioorganic Medicinal Chemistry 18: 7724–7730.CrossRefPubMedGoogle Scholar
- Kinger, M., Y.D. Park, J.H. Park, M.G. Hur, H.J. Jeong, S.J. Park, W.S. Lee, S.W. Kim, and S.D. Yang. 2012. Design, synthesis, and anti-influenza viral activities of 1,3-diarylprop-2-en-1-ones: a novel class of neuraminidase inhibitors. Archives of Pharmacal Research 35: 633–638.CrossRefPubMedGoogle Scholar
- Klunk, W.E., H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, D.P. Holt, M. Bergstrom, I. Savitcheva, G.F. Huang, S. Estrada, B. Ausen, M.L. Debnath, J. Barletta, J.C. Price, J. Sandell, B.J. Lopresti, A. Wall, P. Koivisto, G. Antoni, C.A. Mathis, and B. Langstrom. 2004. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Annals Neurology 55: 306–319.CrossRefGoogle Scholar
- Newberg, A.B., N.A. Wintering, K. Plossl, J. Hochold, M.G. Stabin, M. Watson, D. Skovronsky, C.M. Clark, M.P. Kung, and H.F. Kung. 2006. Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer’s disease. Journal of Nuclear Medicine 47: 748–754.PubMedGoogle Scholar
- Ono, M., R. Watanabe, H. Kawashima, Y. Cheng, H. Kimura, H. Watanabe, M. Haratake, H. Saji, and M. Nakayama. 2009. Fluoro-pegylated chalcones as positron emission tomography probes for in vivo imaging of beta-amyloid plaques in Alzheimer’s disease. Journal of Medicinal Chemistry 52: 6394–6401.CrossRefPubMedGoogle Scholar
- Park, Y.D., J.H. Park, M.G. Hur, S.W. Kim, J.J. Min, S.H. Park, Y.J. Yoo, Y.J. Yoon, and S.D. Yang. 2012. Fluorescent 2-styrylpyridazin-3(2H)-one derivatives as probes targeting amyloid-beta plaques in Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters 22: 4106–4110.CrossRefGoogle Scholar
- Ran, C., X. Xu, S.B. Raymond, B.J. Ferrara, K. Neal, B.J. Bacskai, Z. Medarova, and A. Moore. 2009. Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits. Journal of the American Chemical Society 131: 15257–15261.PubMedCentralCrossRefPubMedGoogle Scholar